THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net


S U M M A R Y


DIARY: June 5, 2008 08:30 AM Thursday; Rod Welch

Millie 2nd treatment 4th cycle cetuximab Carboplatin 4th relapse IBC.

1...Summary/Objective
...Taxotere Capecitabine 2nd Relapse IBC Treatment After Mastectomy
...Cetuxiab Alone Clinical Study
...Cetuxiab with Carboplatin Clinical Study 2nd Arm
2...UCSF Security Forces Disrupt Infusion Clinic Traumatize Patients
3...Security Services Disrupt Work Cafeteria Seating Dispute
4...Work Disrupted Cafeteria Seating Dispute UCSF Security Services
5...Cafeteria Seating Dispute Security Services Investigate Several Months
6...Confidentiality UCSF Security Svcs Investigate Working Efficiently
7...Labs Blood Test
8...Chemotherapy Orders Prescribes 2 Neupogen Treatments 4th Cycle
9...Chemotherapy Order Dated 080529 for Cycle 4 Received from UCSF
10...Error Carboplatin in Chemo Order 080529 Marked Received 080602
11...Neupogen 2 Treatments Weekly Prescribed Chemotherapy Orders 4th Cycle


..............
Click here to comment!

CONTACTS 

SUBJECTS
Cetuximab 12th Cycle 3rd Treatment 18th Total Treatment Chemotherapy

0403 -
0403 -    ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS A3 0000. ref SDS A1 0000.
040502 -
040503 -
040504 -
040505 -
040506 -
040507 -
040508 -
040509 -
040510 -
040512 -  ..
0406 -
0407 -
0408 - Progress
0409 -
040901 - Background on Millie's treatment in the clinical study is reported on
040902 - 080508. ref SDS 99 TZ8I
040904 -    ..
040905 -   Taxotere Capecitabine 2nd Relapse IBC Treatment After Mastectomy
040906 -
040907 -   Follow up ref SDS A3 X33O, ref SDS A1 X33O.
040908 -
040909 -   Millie had left mastectomy on 051021.  Biopsy at that time reported
040910 -   no findings of cancer.  Approximately 8 months later on 060707 the
040911 -   doctor diagnosed IBC relapse and prescribed treatment. ref SDS 2
040912 -   PF3O
040913 -
040914 -    1.  Cycle 09 and 01 ................... 060721, ref SDS 3 407N
040915 -    2.  Cycle 10 and 02 ................... 060814, ref SDS 5 LY6O
040916 -    3.  Cycle 11 and 03 ................... 060908, ref SDS 5 407N
040917 -    4.  Cycle 12 and 04 ................... 060929, ref SDS 5 407N
040918 -    5.  Cycle 13 and 05 ................... 061020, ref SDS 6 407N
040919 -    6.  Cycle 14 and 06 ................... 061110, ref SDS 8 407N
040920 -    7.  Cycle 15 and 07 ................... 061201, ref SDS 9 407N
040922 -    ..
040923 -   Cetuxiab Alone Clinical Study
040924 -
040925 -   Follow up ref SDS A3 356I, ref SDS A1 356I.
040926 -
040927 -                   Total    Cetuximab
040928 -    8.  Cycle 01 and 08 and 01 01.......... 070201, ref SDS 11 SG8I
040929 -    9.  Cycle 01 and 08 and 02 02.......... 070208, ref SDS 12 SG8I
040930 -   10.  Cycle 01 and 08 and 03 03.......... 070215, ref SDS 13 SG8I
040931 -   11.  Cycle 01 and 08 and 04 04.......... 070222, ref SDS 14 SG8I
040932 -   12.  Cycle 02 and 09 and 01 05.......... 070301, ref SDS 15 SG8I
040933 -   13.  Cycle 02 and 09 and 02 06.......... 070308, ref SDS 17 7T3H
040934 -   14.  Cycle 02 and 09 and 03 07.......... 070315, ref SDS 18 7T3H
040935 -   15.  Cycle 02 and 09 and 04 08.......... 070322, ref SDS 19 7T3H
040936 -   16.  Cycle 03 and 10 and 01 09.......... 070329, ref SDS 20 7T3H
040937 -   17.  Cycle 03 and 10 and 02 10.......... 070405, ref SDS 21 7T3H
040938 -   18.  Cycle 03 and 10 and 03 11.......... 070412, ref SDS 22 7T3H
040939 -   19.  Cycle 03 and 10 and 04 12.......... 070419, ref SDS 23 7T3H
040940 -   20.  Cycle 04 and 11 and 01 13.......... 070426, ref SDS 24 7T3H
040941 -   21.  Cycle 04 and 11 and 02 14.......... 070503, ref SDS 25 7T3H
040942 -   22.  Cycle 04 and 11 and 03 15.......... 070510, ref SDS 26 7T3H
040943 -   23.  Cycle 04 and 11 and 04 16.......... 070517, ref SDS 27 7T3H
040944 -   24.  Cycle 05 and 12 and 01 17.......... 070524, ref SDS 28 7T3H
040945 -   25.  Cycle 05 and 12 and 02 18.......... 070531, ref SDS 29 7T3H
040946 -   26.  Cycle 05 and 12 and 03 19.......... 070607, ref SDS 30 7T3H
040947 -   27.  Cycle 05 and 12 and 04 20.......... 070614, ref SDS 31 0001
040948 -   28.  Cycle 06 and 13 and 01 21.......... 070621, ref SDS 32 0001
040949 -   29.  Cycle 06 and 13 and 02 22.......... 070628, ref SDS 33 0001
040950 -   30.  Cycle 06 and 13 and 03 23.......... 070705, ref SDS 34 0001
040951 -   31.  Cycle 06 and 13 and 04 24.......... 070712, ref SDS 35 0001
040952 -   32.  Cycle 07 and 14 and 01 25.......... 070719, ref SDS 36 0001
040953 -   33.  Cycle 07 and 14 and 02 26.......... 070726, ref SDS 37 0001
040954 -   34.  Cycle 07 and 14 and 03 27.......... 070802, ref SDS 35 0001
040955 -   35.  Cycle 07 and 14 and 04 28.......... 070809, ref SDS 39 0001
040956 -   36.  Cycle 08 and 15 and 01 29.......... 070816, ref SDS 40 0001
040957 -   37.  Cycle 08 and 15 and 02 30.......... 070823, ref SDS 41 0001
040958 -   38.  Cycle 08 and 15 and 03 31.......... 070830, ref SDS 41 0001
040959 -   39.  Cycle 08 and 15 and 04 32.......... 070906, ref SDS 42 0001
040960 -   40.  Cycle 09 and 16 and 01 33.......... 070920, ref SDS 43 0001
040961 -   41.  Cycle 09 and 16 and 02 34.......... 070927, ref SDS 44 0001
040962 -   42.  Cycle 09 and 16 and 03 35.......... 071004, ref SDS 45 0001
040963 -   43.  Cycle 09 and 16 and 04 36.......... 071011, ref SDS 46 0001
040964 -   44.  Cycle 10 and 17 and 01 37.......... 071018, ref SDS 47 0001
040965 -   45.  Cycle 10 and 17 and 02 38.......... 071025, ref SDS 48 0001
040966 -   46.  Cycle 10 and 17 and 03 39.......... 071101, ref SDS 49 0001
040967 -   47.  Cycle 10 and 17 and 04 40.......... 071108, ref SDS 50 0001
040968 -   48.  Cycle 11 and 18 and 01 41.......... 071115, ref SDS 51 0001
040969 -   49.  Cycle 11 and 18 and 02 42.......... 071122, ref SDS 37 0001
040970 -   50.  Cycle 11 and 18 and 03 43.......... 071129, ref SDS 53 0001
040971 -   51.  Cycle 11 and 18 and 04 44.......... 071206, ref SDS 54 0001
040972 -   52.  Cycle 12 and 19 and 01 45.......... 071213, ref SDS 57 0001
040973 -   53.  Cycle 12 and 19 and 02 46.......... 071220, ref SDS 60 0001
040974 -   54.  Cycle 12 and 19 and 03 47.......... 071227, ref SDS 61 0001
040975 -   55.  Cycle 12 and 19 and 04 48.......... 080103, ref SDS 62 0001
040976 -   56.  Cycle 13 and 20 and 01 49.......... 080110, ref SDS 65 0001
040977 -   57.  Cycle 13 and 20 and 02 50.......... 080117, ref SDS 66 0001
040978 -   58.  Cycle 13 and 20 and 03 51.......... 080124, ref SDS 67 0001
040979 -   59.  Cycle 13 and 20 and 04 52.......... 080131, ref SDS 69 0001
040980 -   60.  Cycle 14 and 21 and 01 53.......... 080207, ref SDS 73 0001
040981 -   61.  Cycle 14 and 21 and 02 54.......... 080214, ref SDS 74 0001
040982 -   62.  Cycle 14 and 21 and 03 55.......... 080221, ref SDS 35 0001
040983 -   63.  Cycle 14 and 21 and 04 56.......... 080228, ref SDS 80 0001
040984 -   64.  Cycle 15 and 22 and 01 57 01  00... 080306, ref SDS 83 TZ8I
040986 -    ..
040987 -   Cetuxiab with Carboplatin Clinical Study 2nd Arm
040988 -
040989 -   Follow up ref SDS A3 5B6J, ref SDS A1 5B6J.
040990 -
040991 -   On 080207 doctor reports IBC may be spreading. ref SDS 72 GH5H
040992 -   Follow up examination on 080219 Doctor Rugo diagnosed progression of
040993 -   disease. ref SDS 77 3J4I  Photographs show spread of IBC rash,
040994 -
040995 -             2nd
040996 -             Arm              Cetuximab Carboplatin
040997 -   65.  Cycle 01 15 and 22 and 02 58 02  01... 080313, ref SDS 84 TZ8I
040998 -   66.  Cycle 01 15 and 22 and 03 59 03  01... 080320, ref SDS 85 TZ8I
040999 -   67.  Cycle 01 15 and 22 and 04 60 04  01... 080327, ref SDS 86 TZ8I
041000 -   68.  Cycle 02 16 and 23 and 01 61 05  02... 080403, ref SDS 87 TZ8I
041001 -   69.  Cycle 02 16 and 23 and 02 62 06  03... 080410, ref SDS 90 TZ8I
041002 -   70.  Cycle 02 16 and 23 and 03 63 07  03... 080417, ref SDS 92 TZ8I
041003 -   71.  Cycle 02 16 and 23 and 04 64 08  03... 080424, ref SDS 95 TZ8I
041004 -   72.  Cycle 03 17 and 24 and 01 65 09  04... 080501, ref SDS 97 5B6J
041005 -   73.  Cycle 03 17 and 24 and 02 66 10  05... 080508, ref SDS 99 5B6J
041006 -   74.  Cycle 03 17 and 24 and 03 67 11  05... 080515, ref SDS A0 5B6J
041007 -   75.  Cycle 03 17 and 24 and 04 68 12  05... 080522, ref SDS A1 5B6J
041008 -   76.  Cycle 04 18 and 25 and 01 69 13  06... 080529, ref SDS A3 5B6J
041009 -   77.  Cycle 04 18 and 25 and 02 70 14  07... 080605, ref SDS 0 5B6J
041011 -  ..
041012 - Today is the 2nd treatment of the 4th cycle with cetuximab and
041013 - Carboplatin together.  This is the 14th treatment overall with
041014 - cetuximab on the 2nd arm of the clinical study, but is only the 7th
041015 - treatment with Carboplatin due to low blood counts.
041017 -  ..
041018 - Catherine out today.  Diane provided nurse support for Millie's
041019 - treatment.
041020 -
041021 -
041022 -
041023 -
0411 -

SUBJECTS
Patient Interviewed UCSF Security Services Verify Patient Assistant

2903 -
290401 -  ..
290402 - UCSF Security Forces Disrupt Infusion Clinic Traumatize Patients
290403 -
290404 - Follow up ref SDS A2 H756.
290405 -
290406 - Diane commented this morning on excitement last week in the Infusion
290407 - Clinic when the Director of Security Services visited Millie for
290408 - consultation on security of patient medical records. ref SDS A2 H756
290409 - Excitement that compounds stress and anxiety of patients getting
290410 - treatment for cancer resisted meeting in the Infusion Clinic.
290411 - ref SDS A2 H54X  The Security Services representative eventually
290412 - decided in consultation with the Practice Manager to meet with Millie
290413 - in the Infusion Clinic. ref SDS A2 H756
290415 -         ..
290416 -        [...in another record today, Millie's letter submits
290417 -        explanation of this event, ref SDS A4 625Q, and assures UCSF
290418 -        their efforts to maintain patient confidentiality have been
290419 -        exemplary and effective in her case. doctor. ref SDS A4 633Q
290420 -
290421 -
290422 -
2905 -

SUBJECTS
Patient Assistant Role UCSF Security Services Investigate 2 Months C

5703 -
570401 -  ..
570402 - Security Services Disrupt Work Cafeteria Seating Dispute
570403 - Work Disrupted Cafeteria Seating Dispute UCSF Security Services
570404 - Cafeteria Seating Dispute Security Services Investigate Several Months
570405 - Confidentiality UCSF Security Svcs Investigate Working Efficiently
570406 -
570407 - Follow up ref SDS A2 LD7L.
570408 -
570409 - Millie sent a letter to UCSF today that addressed the security problem
570410 - last week impounding customer property without cause, incluidng
570411 - computer and documents. ref SDS A2 LD7L (see Millie's letter reported
570412 - in another record). ref SDS A4 625Q
570414 -  ..
570415 - This morning about 1000, assembled the computer started upstairs to
570416 - visit Millie in the Infusion Clinic, and to get the report on the
570417 - blood test today, etc.  Noticed a UCSF Medical Center Security
570418 - Services officer, Bart Buhay, having a sandwich at a table in the
570419 - cafeteria.  Made introductions and asked about the incident last week
570420 - on 080529. ref SDS A2 LD7L
570422 -  ..
570423 - The security officer, Bart, said the department has been investigating
570424 - Millie's patient assistant using a computer in the cafeteria for
570425 - several months.  The investigation was begun because a cafeteria
570426 - customer complained about another customer working on a computer while
570427 - having lunch, and the computer with the keyboard takes up more than
570428 - one seating postion, which limits seating in the cafeteria at lunch
570429 - time.  The security services department filed a complaint with UCSF
570430 - management that supervises the department, requesting guidance on
570431 - action to take, since there is no law against working while eating.  A
570432 - lot of people read a book, some read and write documents while eating.
570433 - A lot of other customers use computers while having lunch.  The
570434 - security officer said that the department has not been instructed to
570435 - intervene in this matter.  Bart further indicated that the security
570436 - department does not have jurisdiction in the cafeteria.
570438 -  ..
570439 - Bart explained that last week the director took action because a
570440 - senior executive at UCSF got mad about not finding an empty table for
570441 - lunch in the cafeteria.  Rather than take lunch back to the office,
570442 - this person called Security Services.  Peter went to the cafeteria and
570443 - cleared the table as a courtesy for this executive, which aligns with
570444 - analysis last week on 080529. ref SDS A2 H662  In the process, Peter
570445 - noticed Millie's schedule of coming meetings, which were layed out for
570446 - data entry.  People at UCSF are concerned about security of medical
570447 - records, due to news reports that UCSF was selling patient records for
570448 - data mining, marketing, fund raising purposes, reported on 080529,
570449 - ref SDS A2 526J  This causes impulsive reaction by UCSF, who cannot
570450 - disclose to anyone without patient consent, striking out against
570451 - patients who can disclose to everyone at will.  The patient assistant
570452 - role is another oddity, which lead Peter to verify this point with
570453 - Millie.
570455 -  ..
570456 - Bart suggested that during lunch, if it looks like the cafeteria is
570457 - filling up, work on the computer might be moved to another location in
570458 - order to avoid riling up people who are high strung.
570459 -
570460 -
570461 -
570462 -
5705 -

SUBJECTS
Default Null Subject Account for Blank Record

5803 -
580401 -  ..
580402 - Labs Blood Test
580403 -
580404 - Follow up ref SDS A3 FW5N, ref SDS A1 FW5N.
580405 -
580406 - Adding Carboplatin to the treatment protocol now requires weekly blood
580407 - tests to determine if the immune system is strong enough for safe
580408 - chemotherapy treatment, reported on 070201, ref SDS 11 XR40, and citing
580409 - the clinical study protocol received from UCSF on 070116. ref SDS 10
580410 - 5U7Z
580412 -  ..
580413 - During treatment, Catherine submitted results of the test.
580414 -
580429 -     ..
580430 -    Log#:                   080605 08:15
580431 -    <----------------------- U C S F -----------------------> <-------------  Kaiser -------------->
580432 -    Type                 Results   Units        Normal        ACRO   Type            Units        Normal
580433 -     ..
580434 -    CBC with DIFF & PLT CT                                     CBCD
580435 -     ..
580436 -    WBC COUNT               4.0    x10E9/L     3.4  -   10     WBC   WBC x10-3        K/uL     3.4  -  10.0
580437 -    RBC COUNT               4.12   x10E12/L      4  -   5.2    RBC   RBC x10-6        M/uL    3.60  -  5.70
580438 -    HEMOGLOBIN             13.4    g/dL         12  -   15.5   HGB   Hemoglobin       g/dL    11.5  -  15.0
580439 -    HEMATOCRIT             39.6    PERCENT      36  -   46     HCT   Hematocrit       %       34.0  -  46.0
580440 -    MCV                    96      fL           80  -   100    MCV   MCV              fL      80.0  -  100.0
580441 -    MCH                    32.7    pg           26  -   34     MCH
580442 -    MCHC                   34.0    g/dL         31  -   36     MCHC
580443 -    PLATELETS             183      x10E9/L     140  -  450     PLT   Plt x10-3        K/uL     140  -  400
580444 -
580445 -        Performed at Mt Zion Clinic Lab, 1600 Divisadero, San
580446 -        Francisco, CA  94115
580447 -    ..
580448 -     (NEUTS x 1000 = ANC for Kaiser)
580449 -    NEUTS         L         1.55   x10E9/L     1.8  -  6.8     N-A   ANC                      1500
580450 -    Neutrophils    Not Reported                                      Neutrophils       %        50  -  70
580451 -
580452 -        [On 080612 NEUTS 3.77 blood counts rise significantly with 2
580453 -        Neupogen treatments, as prescribed by UCSF. ref SDS A6 PU6K
580455 -     ..
580456 -    LYMPHS                  1.70   x10E9/L     0.9  -  2.9     L-A   Lymphocytes       %        20  -  50
580457 -    MONOS                   0.45   x10E9/L     0.1  -  0.6     M-A   Monocyte          %         0  -  11
580458 -    EOS                     0.24   x10E9/L       0  -  0.4     E-A   Esoinophils       %         1  -  5
580459 -    BASOS                   0.08   x10E9/L       0  -  0.1     B-A   Basophil          %         0  -  2
580460 -
580462 -  ..
580463 - CA 15-3 66 was flat last week, shown by the blood test for 080529
580464 - received from Diane today. ref SDS A3 A16M
580466 -  ..
580467 - NEUTS 1.55 barely high enough for Carboplatin. ref SDS 0 QY6H
580468 -
580469 -
580470 -
5805 -

SUBJECTS
Chemotherapy Orders Prescribes 2 Neupogen Treatments Per Week 4th Cy
Chemotherapy Orders 080529 Prescribes 2 Neupogen Treatments Per Week

7404 -
740501 -  ..
740502 - Chemotherapy Orders Prescribes 2 Neupogen Treatments 4th Cycle
740503 -
740504 - Diane said the Chemotherapy Order in the Medical Chart for the current
740505 - cycle, which began last week on 080529 was received by the Infusion
740506 - Clinic on 080602 [for convenience, the Chemo Orders are reported in
740507 - the record on 080529, ref SDS A3 4Z8H], and prescribes 2 Neupogen
740508 - treatments each week on day 2 and day 3, ref SDS A3 PWSY, which may
740509 - mean Friday and Saturday, or possibly Saturday and Sunday for the
740510 - current 4th cycle.
740511 -
740512 -        [...in another record, Millie's letter commends Diane for
740513 -        taking good care of her patients. ref SDS A4 JO8X
740515 -         ..
740516 -        [... in another record, Millie's letter to UCSF requests copy
740517 -        of Chemotherapy Orders showing prescription for 2 Neupogen
740518 -        treatments on 080529. ref SDS A4 4K4K
740520 -  ..
740521 - New information from Diane today that Millie requires 2 Neupogen
740522 - treatments for each weekly cycle of Carboplatin conflicts with
740523 - guidance from Lynn.  During the meeting with the medical team prior to
740524 - treatment last week on 080529 Lynn advised that only 1 Neupogen
740525 - treatment was prescribed for Saturday, 080531. ref SDS A2 4F42  Millie
740526 - recalled today that last week after meeting with Lynn in the Breast
740527 - Care Clinic on the 2nd floor, during treatment on the 5th floor in the
740528 - Infusion Clinic Catherine confirmed Lynn's instructions to take 1
740529 - Neupogen treatment, but clarified that treatment should be on Sunday,
740530 - 080601, rather than Saturday. ref SDS A3 TE6N
740532 -  ..
740533 - Millie feels totally confused.
740535 -  ..
740536 - Millie explained problems and delays the past few months getting
740537 - Neupogen at the Kaiser Pharmacy to correlate with UCSF Chemotherapy
740538 - Orders, reported on 080502. ref SDS 98 NM3M  A patient getting
740539 - chemotherapy in the chair next to Millie overheard this discussion,
740540 - and reported similar difficulties getting her Neupogen treatments
740541 - prescribed for self-injection from the Pharmacy.  However, UCSF
740542 - changed the procedure so that nurses now give her Neupogen treatments
740543 - in the Infusion Clinic without all the problems.  Millie recalled she
740544 - got Neupogen in the hospital without problems on 061031. ref SDS 7
740545 - 9U65  The doctor at Kaiser keeps ordering her treatments in the
740546 - Infusion Clinic, but coordination between Kaiser and UCSF keep going
740547 - wrong, illustrated by problems on 080502. ref SDS 98 NM5K
740549 -  ..
740550 - Megan was in the Infusion Clinic this morning to see other patients.
740551 - There was brief discussion about clarifying the Chemotherapy Orders in
740552 - relation to discussion during the meeting with medical team on 080529.
740553 - Megan was rushing into the elevator and didn't have time to check the
740554 - Chemotherapy Orders.  She was happy to hear that any mixup causing
740555 - Millie to take only 1 Neupogen treatment last week did not lead to
740556 - missing treatment, since blood counts NEUTS 1.55 turned out high
740557 - enough today, per above. ref SDS 0 QY6H
740559 -  ..
740560 - As the elevator doors were closing, Megan indicated she would check
740561 - with the doctor for the Chemotherapy Orders and let everybody know
740562 - what should be done.
740563 -
740564 -        [... in another record, Millie's letter to UCSF requests copy
740565 -        of Chemotherapy Orders showing prescription for 2 Neupogen
740566 -        treatments on 080529. ref SDS A4 JO9Q
740568 -         ..
740569 -        [On 080612 NEUTS 3.77 blood counts rise significantly with 2
740570 -        Neupogen treatments, as prescribed by UCSF. ref SDS A6 PU6K
740572 -         ..
740573 -        [On 080619 Thomas called for Megan who is out of the office;
740574 -        and he coordinated work on scheduling the next CT test.
740575 -        ref SDS A7 MG5I
740576 -
740578 -  ..
740579 - Chemotherapy Order Dated 080529 for Cycle 4 Received from UCSF
740580 - Error Carboplatin in Chemo Order 080529 Marked Received 080602
740581 - Neupogen 2 Treatments Weekly Prescribed Chemotherapy Orders 4th Cycle
740582 -
740583 - When treatment ended today, Diane gave Millie a copy of Chemotherapy
740584 - Order dated 080529 for the 4th cycle, ref SDS A3 4Z8H, and marked
740585 - received by the Infusion Clinic on 080602. ref SDS A3 MV6O  This
740586 - submission responded to Millie's request in a letter earlier today,
740587 - reported in another redord. ref SDS A4 JO9Q
740589 -  ..
740590 - The Chemo Order dated 080529 seems to prescribe 2 treatments with
740591 - Neupogen, ref SDS A3 PWSY, on each of the 3 weeks when Millie gets
740592 - chemotherapy, as Diane indicated to Millie this morning, per above.
740593 - ref SDS 0 JN38
740595 -  ..
740596 - There is also handwriting on the Chemotherapy Order dated 080529, that
740597 - says "error" on the part that prescribes Carboplatin treatment for
740598 - less than the full dose, and research found that UCSF made a mistake
740599 - reducing the dose beginning with the prior cycle starting on 080501.
740600 - ref SDS A3 PVUQ
740602 -  ..
740603 - Millie was further confused, because the letter to the medical team on
740604 - 080423 specified that Carboplatin should be maintained at the full
740605 - dose in order to optimize recovery from IBC, that has been effective
740606 - at the full dose, ref SDS 93 TY6Y, as shown in the examination at UCSF
740607 - last month on 080501. ref SDS 96 CZ3N and ref SDS 96 LS3J
740608 -
740609 -        [On 080607 confusion about Neupogen caused failure of
740610 -        treatment. ref SDS A5 Q67I
740612 -         ..
740613 -        [On 080625 Millie asks medical team about error in Chemotherapy
740614 -        Orders discovered on 080605. ref SDS A8 PQWV
740616 -         ..
740617 -        [On 080626 Brigid cannot find the Chemotherapy Order for 080529
740618 -        that is marked to show an error on the dose for Carboplatin;
740619 -        requests Millie submit a copy for UCSF files. ref SDS A9 RF3N
740621 -  ..
740622 - Millie has 2 Neupogen treatments on hand from the prescription for 6
740623 - treatments ordered by the primary care physician on 080502.
740624 - ref SDS 98 NL4M  At that time, the doctor made a mistake ordering
740625 - Neupogen treatments, due to confusion about computer commands.
740626 - ref SDS 98 NM4J
740628 -  ..
740629 - Millie can take 2 treatments this week on Saturday and Sunday, which
740630 - exhaust the stock of Neupogen on hand.  Next week is a bye week, and
740631 - the following week starts a new cycle.  Millie meets with the primary
740632 - care physician the next day.
740633 -
740634 -        [On 080607 confusion caused error taking Neupogen, ref SDS A5
740635 -        Q67I; Millie asks medical team about getting more Neupogen to
740636 -        complete prescribed treatment. ref SDS A5 TO5N
740637 -
740638 -
740639 -
740640 -
740641 -
740642 -
740643 -
740644 -
740645 -
7407 -